Akebia Therapeutics, Inc. (AKBA) SEC Filings — 2024

Filings

• Akebia Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
• Akebia Therapeutics Q3 2024: Revenue Down, Net Loss Widens — 10-Q · Nov 7, 2024
• Akebia Therapeutics Files 8-K — 8-K · Nov 7, 2024
• Akebia Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 22, 2024
• Akebia Therapeutics Files 8-K Report — 8-K · Oct 22, 2024
• Akebia Therapeutics Signs Material Definitive Agreement — 8-K · Oct 16, 2024
• Akebia Therapeutics Q2 2024 10-Q Filed — 10-Q · Aug 8, 2024
• Akebia Therapeutics Files 8-K on Financials — 8-K · Aug 8, 2024
• Akebia Therapeutics Terminates Vifor Pharma Agreement — 8-K · Jul 11, 2024
• Akebia Therapeutics Elects New Directors — 8-K · Jun 24, 2024
• Akebia Therapeutics Holds Stockholder Meeting — 8-K · Jun 10, 2024
• Akebia Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• Akebia Therapeutics Files 8-K on Financials — 8-K · May 9, 2024
• Akebia Therapeutics, Inc. Files Definitive Proxy Statement — DEF 14A · Apr 25, 2024
• Akebia Therapeutics Secures $50M Loan — 8-K · Apr 23, 2024
• Akebia Therapeutics Enters Material Definitive Agreement — 8-K · Apr 16, 2024
• Akebia Therapeutics Completes $200M Senior Secured Notes Offering — 8-K · Mar 28, 2024
• Akebia Therapeutics Announces Board Changes and Executive Compensation — 8-K · Mar 15, 2024
• Akebia Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 14, 2024
• Akebia Therapeutics Files 8-K — 8-K · Mar 14, 2024
• Akebia Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Akebia Therapeutics Files 8-K on Officer/Director Changes — 8-K · Feb 13, 2024
• Muneer Satter Holds 16.2M Shares of Akebia Therapeutics — SC 13G/A · Feb 9, 2024
• Akebia Therapeutics Reports New Debt, Equity Sales, and Agreement Changes — 8-K · Jan 30, 2024
• Akebia Therapeutics Files Routine 8-K on Operations & Financial Condition — 8-K · Jan 8, 2024